Related Experiment Video
Updated: Jun 3, 2025

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
LGR4 is essential for maintaining β-cell homeostasis through suppression of RANK
Joanna Filipowska1, Zelda Cisneros1, Sneha S Varghese1
1Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope, Duarte, CA 91010, USA; Department of Translational Research and Cellular Therapeutics, City of Hope, Duarte, CA 91010, USA.
Objective:
Loss of functional β-cell mass is a major cause of diabetes. Thus, identifying regulators of β-cell health is crucial for treating this disease. The Leucine-rich repeat-containing G-protein-coupled receptor (GPCR) 4 (LGR4) is expressed in β-cells and is the fourth most abundant GPCR in human islets. Although LGR4 has regenerative, anti-inflammatory, and anti-apoptotic effects in other tissues, its functional significance in β-cells remains unknown. We have previously identified Receptor Activator of Nuclear Factor Kappa B (NFκB) (RANK) as a negative regulator of β-cell health. In this study, we assessed the regulation of Lgr4 in islets, and the role of LGR4 and LGR4/RANK stoichiometry in β-cell health under basal and stress-induced conditions, in vitro and in vivo.
Methods:
We evaluated Lgr4 expression in mouse and human islets in response to acute (proinflammatory cytokines), or chronic (high fat fed mice, db/db mice, and aging) stress. To determine the role of LGR4 we employed in vitro Lgr4 loss and gain of function in primary rodent and human β-cells and examined its mechanism of action in the rodent INS1 cell line. Using Lgr4fl/fl and Lgr4fl/fl/Rankfl/fl × Ins1-Cre mice we generated β-cell-specific conditional knockout (cko) mice to test the role of LGR4 and its interaction with RANK in vivo under basal and stress-induced conditions.
Results:
Lgr4 expression in rodent and human islets was reduced by multiple stressors. In vitro, Lgr4 knockdown decreased proliferation and survival in rodent β-cells, while overexpression protected against cytokine-induced cell death in rodent and human β-cells. Mechanistically, LGR4 protects β-cells by suppressing RANK- Tumor necrosis factor receptor associated factor 6 (TRAF6) interaction and subsequent activation of NFκB. Lgr4cko mice exhibit normal glucose homeostasis but increased β-cell death in both sexes and decreased β-cell proliferation and maturation only in females. Male Lgr4cko mice under stress displayed reduced β-cell proliferation and a further increase in β-cell death. The impaired β-cell phenotype in Lgr4cko mice was rescued in Lgr4/Rank double ko (dko) mice. Upon aging, both male and female Lgr4cko mice displayed impaired β-cell homeostasis, however, only female mice became glucose intolerant with decreased plasma insulin.
Conclusions:
These data demonstrate a novel role for LGR4 as a positive regulator of β-cell health under basal and stress-induced conditions, through suppressing the negative effects of RANK.
Insights
Leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4) protects beta-cells from death and promotes their health. LGR4 suppresses Receptor Activator of NFκB (RANK) signaling, crucial for diabetes treatment.
Area of Science:
- Endocrinology and Metabolism
- Cell Biology
- Diabetes Research
Background:
- Loss of functional beta-cell mass is a primary driver of diabetes.
- Leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4) is present in human islets, but its role in beta-cell health is unknown.
- Receptor Activator of Nuclear Factor Kappa B (NFκB) (RANK) is a known negative regulator of beta-cell health.
Purpose of the Study:
- To investigate the regulation of Lgr4 in pancreatic islets.
- To determine the role of LGR4 and its interaction with RANK in beta-cell health.
- To assess LGR4 function under basal and stress conditions, both in vitro and in vivo.
Main Methods:
- Evaluated Lgr4 expression in mouse and human islets under various stress conditions (cytokines, high-fat diet, db/db mice, aging).
- Utilized in vitro Lgr4 loss-of-function and gain-of-function studies in primary rodent and human beta-cells.
- Generated beta-cell-specific conditional knockout mice (Lgr4cko and Lgr4/Rank dko) to assess in vivo roles.
Main Results:
- Lgr4 expression decreased under stress; Lgr4 knockdown impaired beta-cell proliferation and survival, while overexpression protected against cell death.
- LGR4 suppresses RANK-TRAF6 interaction, inhibiting NFκB activation and protecting beta-cells.
- Lgr4cko mice showed increased beta-cell death and impaired proliferation/maturation (females), with rescued phenotypes in dko mice and impaired homeostasis in aged Lgr4cko mice.
Conclusions:
- LGR4 acts as a novel positive regulator of beta-cell health under both basal and stress conditions.
- LGR4 exerts its protective effects by antagonizing the detrimental actions of RANK.
- These findings highlight LGR4 as a potential therapeutic target for diabetes.
Related Concept Videos
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Feedback Loops
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...

